Results 61 to 70 of about 466 (135)

Comprehensive Proteomic Analysis of Dysferlinopathy Unveiling Molecular Mechanisms and Biomarkers Linked to Pathological Progression

open access: yesCNS Neuroscience &Therapeutics, Volume 30, Issue 10, October 2024.
The current study is the first to utilize tandem mass tag (TMT)‐labeled liquid chromatography‐mass spectrometry (LC–MS/MS)‐based proteomics in dysferlinopathy research. The study aimed to explore the proteomic landscape and disease‐related alterations in the muscle tissue proteome of 15 patients with dysferlinopathy with varying degrees of dystrophic ...
Di Wang   +13 more
wiley   +1 more source

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 15, Issue 3, Page 1108-1120, June 2024.
Abstract Background Finding sensitive clinical outcome measures has become crucial in natural history studies and therapeutic trials of neuromuscular disorders. Here, we focus on 1‐year longitudinal data from quantitative magnetic resonance imaging (MRI) and phosphorus magnetic resonance spectroscopy (31P MRS) in a placebo‐controlled study of sirolimus
Harmen Reyngoudt   +11 more
wiley   +1 more source

The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3‐related muscular dystrophy

open access: yesMuscle &Nerve, Volume 69, Issue 4, Page 472-476, April 2024.
Abstract Introduction/Aims Limb‐girdle muscular dystrophy R1 (LGMDR1) calpain 3‐related usually presents as a recessively transmitted weakness of proximal limb‐girdle muscles due to pathogenic variants in the CAPN3 gene. Pathogenic variants in this gene have also been found in patients with an autosomal dominantly inherited transmission pattern (LGMDD4)
Andrea Valls   +6 more
wiley   +1 more source

Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis

open access: yesSkeletal Muscle, 2017
Background Previous studies in patients with limb-girdle muscular dystrophy type 2A (LGMD2A) have suggested that calpain-3 (CAPN3) mutations result in aberrant regeneration in muscle.
Mehmet E. Yalvac   +9 more
doaj   +1 more source

The role of magnetic resonance imaging in diagnosing limb-girdle muscular dystrophy: a descriptive exploratory diagnostic study

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited neuromuscular disorders characterized by progressive weakness of the pelvic and shoulder girdle muscles.
Sara Mohamed Ihab   +4 more
doaj   +1 more source

Limb-girdle muscular dystrophy in Brazilian children: clinical, histological and molecular characterization

open access: yesArquivos de Neuro-Psiquiatria, 2014
Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetic muscular dystrophies, involving 16 autosomal recessive subtypes and eight autosomal dominant subtypes.
Marco A. Veloso Albuquerque
doaj   +1 more source

Calpainopathy (LGMD2A) in Croatia: molecular and haplotype analysis

open access: yesCroatian medical journal, 2005
Calpainopathy or limb-girdle muscular dystrophy type 2A (LGMD2A) is one autosomal recessive muscular disorder caused by mutations in calpain3 (CAPN3) gene. We report results concerning LGMD2A obtained during 6-year long prospective and on going genetic and epidemiological study of muscular dystrophies in Croatia.
openaire  

Calpainopathy in Chile, first cases reported

open access: yesNeuromuscular Disorders, 2016
Bevilacqua, Jorge   +18 more
openaire   +2 more sources

Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods. [PDF]

open access: yesJ Neuromuscul Dis
Bardakov SN   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy